Wachtell, Lipton, Rosen & Katz and Allen & Overy advised Swiss drugmaker Novartis on its $28 billion acquisition of a majority stake in Alcon, the world’s largest eye-care company, according to the firms and sources familiar with the deal.

Cravath, Swaine & Moore advised Nestlé. The company owned all of Alcon from 1977 through 2002; it will have multiplied the value of its investment in the eye-care company by about 100 times with Monday’s sale of the 52 percent stake of the company it still owned, according to Bloomberg.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]